589 related articles for article (PubMed ID: 21538000)
1. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Nov; 116(11):2165-9. PubMed ID: 19700197
[TBL] [Abstract][Full Text] [Related]
3. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion.
Lee WJ; Kang MH; Seong M; Cho HY
Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Engelbrecht C; Sardinha LR; Rizzo LV
Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema.
Noma H; Mimura T; Masahara H; Shimada K
Retina; 2014 Feb; 34(2):352-9. PubMed ID: 23842103
[TBL] [Abstract][Full Text] [Related]
8. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
Schoenberger SD; Kim SJ; Sheng J; Rezaei KA; Lalezary M; Cherney E
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5906-11. PubMed ID: 22871833
[TBL] [Abstract][Full Text] [Related]
9. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma.
Usui Y; Wakabayashi Y; Okunuki Y; Kimura K; Tajima K; Matsuda R; Ueda S; Ma J; Nagai T; Mori H; Kezuka T; Nagao T; Goto H
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5395-402. PubMed ID: 22789925
[TBL] [Abstract][Full Text] [Related]
10. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
11. Intraocular tumour necrosis factor ligand related molecule 1 A links disease progression of proliferative diabetic retinopathy after primary vitrectomy.
Wang T; Li J; Xie R; Wang J; Zhang W; Jiang F; Du M; Wang X; Huang B; Brant R; Zhang C; Yan H
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):966-976. PubMed ID: 32064668
[TBL] [Abstract][Full Text] [Related]
12. Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy.
Hang H; Yuan S; Yang Q; Yuan D; Liu Q
Mol Vis; 2014; 20():1137-45. PubMed ID: 25253986
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
15. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
[TBL] [Abstract][Full Text] [Related]
16. Vitreous expression of cytokines and growth factors in patients with diabetic retinopathy-An investigation of their expression based on clinical diabetic retinopathy grade.
Deuchler S; Schubert R; Singh P; Chedid A; Brui N; Kenikstul N; Kohnen T; Ackermann H; Koch F
PLoS One; 2021; 16(5):e0248439. PubMed ID: 34010297
[TBL] [Abstract][Full Text] [Related]
17. Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K
Int Ophthalmol; 2011 Oct; 31(5):393-402. PubMed ID: 22105941
[TBL] [Abstract][Full Text] [Related]
18. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
19. Vitreous inflammatory factors in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Harino S; Mimura T; Eguchi S; Hori S
Jpn J Ophthalmol; 2011 May; 55(3):248-255. PubMed ID: 21538003
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
Yoshimura T; Sonoda KH; Sugahara M; Mochizuki Y; Enaida H; Oshima Y; Ueno A; Hata Y; Yoshida H; Ishibashi T
PLoS One; 2009 Dec; 4(12):e8158. PubMed ID: 19997642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
